Skip to main content
Top
Published in: Current Diabetes Reports 2/2017

01-02-2017 | Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

Workplace Interventions to Prevent Type 2 Diabetes Mellitus: a Narrative Review

Authors: Dina Hafez, Allison Fedewa, Margaret Moran, Matthew O’Brien, Ronald Ackermann, Jeffrey T. Kullgren

Published in: Current Diabetes Reports | Issue 2/2017

Login to get access

Abstract

Purpose of review

This study aims to summarize the recent peer-reviewed literature on workplace interventions for prevention of type 2 diabetes mellitus (T2DM), including studies that translate the Diabetes Prevention Program (DPP) curriculum to workplace settings (n = 10) and those that use different intervention approaches to achieve the specific objective of T2DM prevention among employees (n = 3).

Recent findings

Weight reduction was achieved through workplace interventions to prevent T2DM, though such interventions varied substantially in their effectiveness. The greatest weight loss was reported among intensive lifestyle interventions (i.e., at least 4 months in duration) that implemented the structured DPP curriculum (n = 3). Weight reduction was minimal among less intensive interventions, including those that substantially modified the DPP curriculum (n = 2) and those that used non-DPP intervention approaches to prevent T2DM (n = 3). Most studies (n = 12) reported increased levels of physical activity following the intervention.

Summary

Implementation of the DPP in workplaces may be an effective strategy to prevent T2DM among employees.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002;25:23–9.CrossRefPubMed Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002;25:23–9.CrossRefPubMed
5.
go back to reference Group DPPR, others. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393.CrossRef Group DPPR, others. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393.CrossRef
6.
go back to reference Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. Am J Prev Med. 2008;35:357–63.CrossRefPubMedPubMedCentral Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. Am J Prev Med. 2008;35:357–63.CrossRefPubMedPubMedCentral
7.
go back to reference Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention. Am J Prev Med. 2013;44:S301–6.CrossRefPubMed Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention. Am J Prev Med. 2013;44:S301–6.CrossRefPubMed
8.
go back to reference Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31:67–75.CrossRef Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31:67–75.CrossRef
9.
go back to reference Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173:113.CrossRefPubMed Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173:113.CrossRefPubMed
10.
go back to reference McTigue KM, Conroy MB, Bigi L, Murphy C, McNeil M. Weight loss through living well: translating an effective lifestyle intervention into clinical practice. Diabetes Educ. 2009;35:199–208.CrossRefPubMed McTigue KM, Conroy MB, Bigi L, Murphy C, McNeil M. Weight loss through living well: translating an effective lifestyle intervention into clinical practice. Diabetes Educ. 2009;35:199–208.CrossRefPubMed
11.
go back to reference Whittemore R, Melkus G, Wagner J, Dziura J, Northrup V, Grey M. Translating the Diabetes Prevention Program to primary care: a pilot study. Nurs Res. 2009;58:2–12.CrossRefPubMedPubMedCentral Whittemore R, Melkus G, Wagner J, Dziura J, Northrup V, Grey M. Translating the Diabetes Prevention Program to primary care: a pilot study. Nurs Res. 2009;58:2–12.CrossRefPubMedPubMedCentral
16.
go back to reference Schmittdiel JA, Brown SD, Neugebauer R, Adams SR, Adams AS, Wiley D, et al. Health-plan and employer-based wellness programs to reduce diabetes risk: the Kaiser Permanente Northern California NEXT-D study. Prev. Chronic. Dis. [Internet]. 2013 [cited 2016 Aug 9];10. Available from: http://www.cdc.gov/pcd/issues/2013/12_0146.htm Schmittdiel JA, Brown SD, Neugebauer R, Adams SR, Adams AS, Wiley D, et al. Health-plan and employer-based wellness programs to reduce diabetes risk: the Kaiser Permanente Northern California NEXT-D study. Prev. Chronic. Dis. [Internet]. 2013 [cited 2016 Aug 9];10. Available from: http://​www.​cdc.​gov/​pcd/​issues/​2013/​12_​0146.​htm
17.
go back to reference Lindström J, Neumann A, Sheppard K, Gilis-Januszewska A, Greaves C, Handke U, et al. Take action to prevent diabetes—the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res. 2010;42:S37–55.CrossRefPubMed Lindström J, Neumann A, Sheppard K, Gilis-Januszewska A, Greaves C, Handke U, et al. Take action to prevent diabetes—the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res. 2010;42:S37–55.CrossRefPubMed
21.
go back to reference Goetzel RZ, Ozminkowski RJ. The health and cost benefits of work site health-promotion programs. Annu Rev Public Health. 2008;29:303–23.CrossRefPubMed Goetzel RZ, Ozminkowski RJ. The health and cost benefits of work site health-promotion programs. Annu Rev Public Health. 2008;29:303–23.CrossRefPubMed
22.
go back to reference Laws RA, St. George AB, Rychetnik L, Bauman AE. Diabetes prevention research. Am J Prev Med. 2012;43:205–14.CrossRefPubMed Laws RA, St. George AB, Rychetnik L, Bauman AE. Diabetes prevention research. Am J Prev Med. 2012;43:205–14.CrossRefPubMed
23.
go back to reference Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37:922–33.CrossRefPubMed Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37:922–33.CrossRefPubMed
24.
go back to reference Kruger J, Yore MM, Bauer DR, Kohl HW. Selected barriers and incentives for worksite health promotion services and policies. Am J Health Promot AJHP. 2007;21:439–47.CrossRefPubMed Kruger J, Yore MM, Bauer DR, Kohl HW. Selected barriers and incentives for worksite health promotion services and policies. Am J Health Promot AJHP. 2007;21:439–47.CrossRefPubMed
26.
go back to reference Kaspin LC, Gorman KM, Miller RM. Systematic review of employer-sponsored wellness strategies and their economic and health-related outcomes. Popul Health Manag. 2013;16:14–21.CrossRefPubMed Kaspin LC, Gorman KM, Miller RM. Systematic review of employer-sponsored wellness strategies and their economic and health-related outcomes. Popul Health Manag. 2013;16:14–21.CrossRefPubMed
27.
go back to reference Linnan L, Bowling M, Childress J, Lindsay G, Blakey C, Pronk S, et al. Results of the 2004 national worksite health promotion survey. Am J Public Health. 2008;98:1503–9.CrossRefPubMedPubMedCentral Linnan L, Bowling M, Childress J, Lindsay G, Blakey C, Pronk S, et al. Results of the 2004 national worksite health promotion survey. Am J Public Health. 2008;98:1503–9.CrossRefPubMedPubMedCentral
28.
go back to reference Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings. Health Aff (Millwood). 2010;29:304–11.CrossRef Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings. Health Aff (Millwood). 2010;29:304–11.CrossRef
30.
go back to reference Venditti EM, Kramer MK. Necessary components for lifestyle modification interventions to reduce diabetes risk. Curr Diab Rep. 2012;12:138–46.CrossRefPubMed Venditti EM, Kramer MK. Necessary components for lifestyle modification interventions to reduce diabetes risk. Curr Diab Rep. 2012;12:138–46.CrossRefPubMed
31.
go back to reference A recommendation to improve employee weight status through worksite health promotion programs targeting nutrition, physical activity, or both. Am. J. Prev. Med. 2009;37:358–9. A recommendation to improve employee weight status through worksite health promotion programs targeting nutrition, physical activity, or both. Am. J. Prev. Med. 2009;37:358–9.
32.
go back to reference Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed
34.
go back to reference Anderson LM, Quinn TA, Glanz K, Ramirez G, Kahwati LC, Johnson DB, et al. The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity. Am J Prev Med. 2009;37:340–57.CrossRefPubMed Anderson LM, Quinn TA, Glanz K, Ramirez G, Kahwati LC, Johnson DB, et al. The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity. Am J Prev Med. 2009;37:340–57.CrossRefPubMed
36.
37.
go back to reference Leutzinger J, Pirner M, Landschulz W, Nevins RL, Sullivan S, Silberman C. Metabolic syndrome and worksite health promotion. Am J Health Promot AJHP. 2006;21:1–11. Leutzinger J, Pirner M, Landschulz W, Nevins RL, Sullivan S, Silberman C. Metabolic syndrome and worksite health promotion. Am J Health Promot AJHP. 2006;21:1–11.
38.
go back to reference Aldana SG, Barlow M, Smith R, Yanowitz FG, Adams T, Loveday L, et al. The diabetes prevention program: a worksite experience. AAOHN J Off J Am Assoc Occup Health Nurses. 2005;53:499–505-507. Aldana SG, Barlow M, Smith R, Yanowitz FG, Adams T, Loveday L, et al. The diabetes prevention program: a worksite experience. AAOHN J Off J Am Assoc Occup Health Nurses. 2005;53:499–505-507.
39.
go back to reference Aldana S, Barlow M, Smith R, Yanowitz F, Adams T, Loveday L, et al. A worksite diabetes prevention program: two-year impact on employee health. AAOHN J Off J Am Assoc Occup Health Nurses. 2006;54:389–95. Aldana S, Barlow M, Smith R, Yanowitz F, Adams T, Loveday L, et al. A worksite diabetes prevention program: two-year impact on employee health. AAOHN J Off J Am Assoc Occup Health Nurses. 2006;54:389–95.
40.
go back to reference Barham K, West S, Trief P, Morrow C, Wade M, Weinstock RS. Diabetes prevention and control in the workplace: a pilot project for county employees. J Public Health Manag Pract. 2011;17:233–41.CrossRefPubMed Barham K, West S, Trief P, Morrow C, Wade M, Weinstock RS. Diabetes prevention and control in the workplace: a pilot project for county employees. J Public Health Manag Pract. 2011;17:233–41.CrossRefPubMed
41.
go back to reference Dallam GM, Foust CP. A comparative approach to using the diabetes prevention program to reduce diabetes risk in a worksite setting. Health Promot Pract. 2013;14:199–204.CrossRefPubMed Dallam GM, Foust CP. A comparative approach to using the diabetes prevention program to reduce diabetes risk in a worksite setting. Health Promot Pract. 2013;14:199–204.CrossRefPubMed
42.
go back to reference DeJoy DM, Padilla HM, Wilson MG, Vandenberg RJ, Davis MA. Worksite translation of the diabetes prevention program formative research and pilot study results from FUEL Your Life. Health Promot Pract. 2012;22:1524839912461014. DeJoy DM, Padilla HM, Wilson MG, Vandenberg RJ, Davis MA. Worksite translation of the diabetes prevention program formative research and pilot study results from FUEL Your Life. Health Promot Pract. 2012;22:1524839912461014.
44.
go back to reference Giese KK, Cook PF. Reducing obesity among employees of a manufacturing plant: translating the Diabetes Prevention Program to the workplace. Workplace Health Saf. 2014;62:136.PubMed Giese KK, Cook PF. Reducing obesity among employees of a manufacturing plant: translating the Diabetes Prevention Program to the workplace. Workplace Health Saf. 2014;62:136.PubMed
45.
go back to reference • Kramer MK, Molenaar DM, Arena VC, Venditti EM, Meehan RJ, Miller RG, et al. Improving employee health: evaluation of a worksite lifestyle change program to decrease risk factors for diabetes and cardiovascular disease. J Occup Environ Med. 2015;57:284–91. This study shows favorable weight loss outcomes in a workplace Diabetes Prevention Program, which offered participants in-person and DVD options.CrossRefPubMedPubMedCentral • Kramer MK, Molenaar DM, Arena VC, Venditti EM, Meehan RJ, Miller RG, et al. Improving employee health: evaluation of a worksite lifestyle change program to decrease risk factors for diabetes and cardiovascular disease. J Occup Environ Med. 2015;57:284–91. This study shows favorable weight loss outcomes in a workplace Diabetes Prevention Program, which offered participants in-person and DVD options.CrossRefPubMedPubMedCentral
46.
go back to reference Townsend CKM, Miyamoto RES, Antonio M, Zhang G, Paloma D, Basques D, et al. The PILI@Work Program: a translation of the diabetes prevention program to Native Hawaiian-serving worksites in Hawai‘i. Transl Behav Med. 2016;6:190–201.CrossRefPubMedPubMedCentral Townsend CKM, Miyamoto RES, Antonio M, Zhang G, Paloma D, Basques D, et al. The PILI@Work Program: a translation of the diabetes prevention program to Native Hawaiian-serving worksites in Hawai‘i. Transl Behav Med. 2016;6:190–201.CrossRefPubMedPubMedCentral
47.
go back to reference • Weinhold KR, Miller CK, Marrero DG, Nagaraja HN, Focht BC, Gascon GM. A randomized controlled trial translating the Diabetes Prevention Program to a university worksite, Ohio, 2012–2014. Prev Chronic Dis. 2015;8:12. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674443/. This study shows favorable weight loss outcomes in a 16-week workplace Diabetes Prevention Program. • Weinhold KR, Miller CK, Marrero DG, Nagaraja HN, Focht BC, Gascon GM. A randomized controlled trial translating the Diabetes Prevention Program to a university worksite, Ohio, 2012–2014. Prev Chronic Dis. 2015;8:12. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4674443/​.​ This study shows favorable weight loss outcomes in a 16-week workplace Diabetes Prevention Program.
48.
go back to reference Zyriax B-C, Letsch B, Stock S, Windler E. DELIGHT (Delay of impaired glucose tolerance by a healthy lifestyle trial)—a feasibility study on implementing a program of sustainable diabetes prevention in German companies. Exp Clin Endocrinol Diabetes. 2013;122:20–6.CrossRefPubMed Zyriax B-C, Letsch B, Stock S, Windler E. DELIGHT (Delay of impaired glucose tolerance by a healthy lifestyle trial)—a feasibility study on implementing a program of sustainable diabetes prevention in German companies. Exp Clin Endocrinol Diabetes. 2013;122:20–6.CrossRefPubMed
49.
go back to reference Bevis CC, Nogle JM, Forges B, Chen PC, Sievers D, Lucas KR, et al. Diabetes wellness care: a successful employer-endorsed program for employees. J Occup Environ Med. 2014;56:1052–61.CrossRefPubMed Bevis CC, Nogle JM, Forges B, Chen PC, Sievers D, Lucas KR, et al. Diabetes wellness care: a successful employer-endorsed program for employees. J Occup Environ Med. 2014;56:1052–61.CrossRefPubMed
50.
go back to reference Burton WN, Chen C-Y, Li X, Erickson D, McCluskey M, Schultz A. A worksite occupational health clinic-based diabetes mellitus management program. Popul Health Manag. 2015;18:429–36.CrossRefPubMed Burton WN, Chen C-Y, Li X, Erickson D, McCluskey M, Schultz A. A worksite occupational health clinic-based diabetes mellitus management program. Popul Health Manag. 2015;18:429–36.CrossRefPubMed
51.
go back to reference Viitasalo K, Hemiö K, Puttonen S, Hyvärinen H-K, Leiviskä J, Härmä M, et al. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness. Prim Care Diabetes. 2015;9:96–104.CrossRefPubMed Viitasalo K, Hemiö K, Puttonen S, Hyvärinen H-K, Leiviskä J, Härmä M, et al. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness. Prim Care Diabetes. 2015;9:96–104.CrossRefPubMed
53.
go back to reference Neamah HH, Kuhlmann AKS, Tabak RG. Effectiveness of program modification strategies of the diabetes prevention program: a systematic review. Diabetes Educ. 2016;15:145721716630386. Neamah HH, Kuhlmann AKS, Tabak RG. Effectiveness of program modification strategies of the diabetes prevention program: a systematic review. Diabetes Educ. 2016;15:145721716630386.
54.
go back to reference Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–7.CrossRefPubMedPubMedCentral Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–7.CrossRefPubMedPubMedCentral
55.
go back to reference Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, et al. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes. 2008;32:1537–44.CrossRef Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, et al. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes. 2008;32:1537–44.CrossRef
56.
go back to reference •• Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, et al. Cardiometabolic risk factor changes observed in Diabetes Prevention Programs in US Settings: a systematic review and meta-analysis. PLoS Med. 2016;13:e1002095. This is the most recent systematic review and meta-analysis of 44 translational Diabetes Prevention Programs in community and clinical settings.CrossRefPubMedPubMedCentral •• Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, et al. Cardiometabolic risk factor changes observed in Diabetes Prevention Programs in US Settings: a systematic review and meta-analysis. PLoS Med. 2016;13:e1002095. This is the most recent systematic review and meta-analysis of 44 translational Diabetes Prevention Programs in community and clinical settings.CrossRefPubMedPubMedCentral
57.
go back to reference Goetzel RZ, Henke RM, Tabrizi M, Pelletier KR, Loeppke R, Ballard DW, et al. Do workplace health promotion (wellness) programs work? J Occup Environ Med. 2014;56:927–34.CrossRefPubMed Goetzel RZ, Henke RM, Tabrizi M, Pelletier KR, Loeppke R, Ballard DW, et al. Do workplace health promotion (wellness) programs work? J Occup Environ Med. 2014;56:927–34.CrossRefPubMed
58.
go back to reference Henke RM, Goetzel RZ, McHugh J, Isaac F. Recent experience in health promotion at Johnson & Johnson: lower health spending. Strong Return On Investment Health Aff (Millwood). 2011;30:490–9.CrossRef Henke RM, Goetzel RZ, McHugh J, Isaac F. Recent experience in health promotion at Johnson & Johnson: lower health spending. Strong Return On Investment Health Aff (Millwood). 2011;30:490–9.CrossRef
59.
go back to reference Johnson M, Jones R, Freeman C, Woods HB, Gillett M, Goyder E, et al. Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence. Diabet Med. 2013;30:3–15.CrossRefPubMed Johnson M, Jones R, Freeman C, Woods HB, Gillett M, Goyder E, et al. Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence. Diabet Med. 2013;30:3–15.CrossRefPubMed
60.
go back to reference Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008;41:327–50.CrossRefPubMed Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008;41:327–50.CrossRefPubMed
Metadata
Title
Workplace Interventions to Prevent Type 2 Diabetes Mellitus: a Narrative Review
Authors
Dina Hafez
Allison Fedewa
Margaret Moran
Matthew O’Brien
Ronald Ackermann
Jeffrey T. Kullgren
Publication date
01-02-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 2/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0840-0

Other articles of this Issue 2/2017

Current Diabetes Reports 2/2017 Go to the issue

Diabetes and Pregnancy (MF Hivert, Section Editor)

Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Management of Hyperglycemia and Diabetes in Orthopedic Surgery

Other Forms of Diabetes and Its Complications (JJ Nolan, Section Editor)

Diabetes in Patients With Acromegaly

Other Forms of Diabetes and Its Complications (JJ Nolan, Section Editor)

Diabetes Secondary to Treatment with Statins

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.